↓ Skip to main content

Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics

Overview of attention for article published in Clinical and Translational Oncology, January 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
16 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
47 Mendeley